Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Spero Therapeutics Inc (NQ: SPRO ) 1.280 +0.020 (+1.59%) Streaming Delayed Price Updated: 4:00 PM EDT, Aug 9, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 62,144 Open 1.280 Bid (Size) 1.250 (236) Ask (Size) 1.300 (1) Prev. Close 1.260 Today's Range 1.250 - 1.290 52wk Range 0.9900 - 1.890 Shares Outstanding 52,571,813 Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News SPRO Stock Earnings: Spero Therapeutics Beats EPS, Beats Revenue for Q2 2024 August 05, 2024 SPRO stock results show that Spero Therapeutics beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024. Via InvestorPlace 3 Micro-Cap Moonshots for Fearless Investors July 08, 2024 Investors should know the risks of micro-cap stocks before looking into these three high-potential companies with low prices. Via InvestorPlace Performance YTD -15.79% -15.79% 1 Month -5.88% -5.88% 3 Month -21.95% -21.95% 6 Month -6.57% -6.57% 1 Year -11.72% -11.72% More News Read More SPRO Stock Earnings: Spero Therapeutics Misses EPS, Misses Revenue for Q1 2024 May 15, 2024 Via InvestorPlace Why Robinhood Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket March 14, 2024 Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday March 14, 2024 Via InvestorPlace Recap: Spero Therapeutics Q4 Earnings March 13, 2024 Via Benzinga Earnings Outlook For Spero Therapeutics March 12, 2024 Via Benzinga Why Limbach Holdings Shares Are Trading Lower By Around 15%? Here Are Other Stocks Moving In Thursday's Mid-Day Session March 14, 2024 Via Benzinga 5 Value Stocks In The Healthcare Sector December 04, 2023 Via Benzinga 12 Health Care Stocks Moving In Tuesday's After-Market Session November 14, 2023 Via Benzinga Recap: Spero Therapeutics Q3 Earnings November 13, 2023 Via Benzinga Earnings Outlook For Spero Therapeutics November 10, 2023 Via Benzinga 4 Analysts Have This to Say About Spero Therapeutics September 05, 2023 Via Benzinga Earnings Scheduled For March 13, 2024 March 13, 2024 Via Benzinga 12 Health Care Stocks Moving In Monday's After-Market Session November 13, 2023 Via Benzinga Spero Therapeutics's Earnings: A Preview August 09, 2023 Via Benzinga Recap: Spero Therapeutics Q1 Earnings May 11, 2023 Via Benzinga Spero Therapeutics's Earnings Outlook May 10, 2023 Via Benzinga Earnings Scheduled For November 13, 2023 November 13, 2023 Via Benzinga SPERO ALERT: Bragar Eagel & Squire, P.C. is Investigating Spero Therapeutics, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm November 02, 2023 From Bragar Eagel & Squire, P.C. Via Business Wire Overview Of Value Stocks In The Healthcare Sector September 18, 2023 Via Benzinga HC Wainwright & Co. Maintains Buy Rating for Spero Therapeutics: Here's What You Need To Know August 14, 2023 Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday March 31, 2023 Via InvestorPlace Earnings Scheduled For August 10, 2023 August 10, 2023 Via Benzinga Earnings Scheduled For May 11, 2023 May 11, 2023 Via Benzinga Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
